Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Antihemophilic Factor VIII Human (Humate P) (HCPCS Q2022) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 16, 2026 , from http://ppman.hank.ai/transparency/procedure/Q2022/by-state?code_type=HCPCS
“Antihemophilic Factor VIII Human (Humate P) (HCPCS Q2022) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/Q2022/by-state?code_type=HCPCS. Accessed
November 16, 2026 .
“Antihemophilic Factor VIII Human (Humate P) (HCPCS Q2022) by State,” HANK Price Transparency ,
accessed November 16, 2026 ,
http://ppman.hank.ai/transparency/procedure/Q2022/by-state?code_type=HCPCS.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
HCPCS · across United States
Q2022 — Antihemophilic Factor Viii Human (Humate P)
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,970
National median
$74 – $2,393
IQR (p25 – p75)
23
hospitals filing
10
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for Q2022 (HCPCS), with interquartile range
State Median p25 p75
NJ $1 $1 $1
TX $1 $1 $1
LA $1 $1 $1
NY $1 $1 $1
MI $2 $2 $2
PA $21 $1 $42
NH $74 $74 $74
TN $90 $58 $90
WV $95 $95 $95
IN $2,209 $1,970 $2,804